Researchers, including those from University of Birmingham in the UK, used electroencephalogram (EEG) - a test that detects electrical activity in a person’s brain via electrodes attached to their scalp - on a group of 25 patients to establish how quickly they processed words shown to them on a computer screen.
The study, published in the journal Neuroimage Clinical, analysed a mix of healthy elderly people, patients with mild cognitive impairment (MCI), and patients with MCI who had developed Alzheimer’s within three years of diagnosis of MCI.
MCI, a condition in which someone has minor problems with mental abilities such as memory beyond what would normally be expected for a healthy person of their age, is estimated to be suffered by up to 20 per cent of people aged over 65.
It is not a type of dementia, but a person with MCI is more likely to go on to develop dementia, researchers said.
A prominent feature of Alzheimer’s is a progressive decline in language, however, the ability to process language in the period between the appearance of initial symptoms of Alzheimer’s to its full development has scarcely previously been investigated, researchers said.
“We focused on language functioning, since it is a crucial aspect of cognition and particularly impacted during the progressive stages of Alzheimer’s,” said Ali Mazaheri, from University of Birmingham.
Previous research has found that when a person is shown a written word, it takes 250 milliseconds for the brain to process it — activity which can be picked up on an EEG.
“Crucially, what we found in our study is that this brain response is aberrant in individuals who will go on in the future to develop Alzheimer’s disease, but intact in patients who remained stable, said Katrien Segaert, of the University of Birmingham.
“Our findings were unexpected as language is usually affected by Alzheimer’s disease in much later stages of the onset of the disease,” Segaert said.
It is possible that this breakdown of the brain network associated with language comprehension in MCI patients could be a crucial biomarker used to identify patients likely to develop Alzheimer’s disease, researchers said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)